サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1346868

デジタルバイオマーカーの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Digital Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 281 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
デジタルバイオマーカーの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 281 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デジタルバイオマーカー市場の世界需要は、調査期間2023～2030年のCAGR23.5%で、2022年の36億米ドルから2030年には194億8,000万米ドル近くの市場規模に達すると推定されます。

デジタルバイオマーカーとは、ウェアラブル、スマートフォン、センサー、その他の接続ツールを含むデジタル機器や技術を通じて収集された測定可能で定量化可能な健康関連データを指します。これらのデータポイントは、個人の健康や行動の様々な側面をリアルタイムで監視・分析するために使用されます。これらのバイオマーカーは、個人の生理学的、心理学的、行動パターンに関する貴重な洞察を提供し、ヘルスケア専門家や研究者が個人の幸福についてより総合的な理解を得ることを可能にします。

市場力学：

デジタルバイオマーカー市場は、ヘルスケアへの技術の統合を推進する様々な要因の組み合わせにより、力強い成長を遂げています。ウェアラブルデバイス、遠隔モニタリング、データ分析の進歩により、リアルタイムの健康データの収集が可能になり、デジタルバイオマーカーの基盤が形成されています。これらのバイオマーカーは、個別化ヘルスケア、予防アプローチ、健康問題の早期発見を促進します。スマートフォンの普及と高齢化、慢性疾患の増加が相まって、遠隔モニタリング・ソリューションの需要が高まっています。これらのバイオマーカーは、メンタルヘルス・モニタリングや臨床試験にも有用であり、規制当局のサポートや消費者の意識が、その採用をさらに後押ししています。とはいえ、データのプライバシーや正確性といった課題には注意を払う必要があります。技術、ヘルスケアニーズ、患者のエンパワーメントの融合がデジタルバイオマーカー市場の拡大を支えており、ヘルスケア提供や調査手法に革命をもたらしています。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析を対象としています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはデジタルバイオマーカーの世界市場における各セグメントを包括的に評価することもできます。デジタルバイオマーカー産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカのデジタルバイオマーカー市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、すべての主要地域における個々の用途セグメントの需要、推定・予測にも焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 デジタルバイオマーカー- 産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 デジタルバイオマーカーの世界市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • ウェアラブル
  • モバイルベースアプリケーション
  • センサー
  • その他

第6章 デジタルバイオマーカーの世界市場分析：臨床診療別

  • 臨床診療別概要
  • 実績データと予測データ
  • 臨床診療別分析
  • 診断用デジタルバイオマーカー
  • モニタリングデジタルバイオマーカー
  • 予測・予後デジタルバイオマーカー
  • その他（安全性、薬物動態／反応性、感受性）

第7章 デジタルバイオマーカーの世界市場分析：治療領域別

  • 治療領域別概要
  • 実績データと予測データ
  • 治療領域別分析
  • 心血管および代謝疾患（CVMD）
  • 呼吸器疾患
  • 精神疾患
  • 睡眠および運動疾患
  • 神経疾患
  • 筋骨格系疾患
  • その他（糖尿病、疼痛管理）

第8章 デジタルバイオマーカーの世界市場分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • ヘルスケア企業
  • ヘルスケアプロバイダー
  • 支払者
  • その他（患者、介護者）

第9章 デジタルバイオマーカーの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東とアフリカ

第10章 デジタルバイオマーカー企業の競合情勢

  • デジタルバイオマーカー市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第11章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • ActiGraph LLC
  • AliveCor Inc.
  • Koneksa
  • Altoida Inc.
  • Amgen Inc.
  • Biogen Inc.
  • Empatica Inc.
  • Vivo Sense
  • IXICO plc
  • Adherium Limited
  • Neurotrack Technologies Inc.
  • Aural Analytic
  • Huma
  • Sonde Health Inc.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Wearable Market Sales by Geography (USD MN)
  • Mobile Based Applications Market Sales by Geography (USD MN)
  • Sensors Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Clinical Practice (USD MN)
  • Diagnostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Monitoring Digital Biomarkers Market Sales by Geography (USD MN)
  • Predictive And Prognostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Other's (Safety, Pharmaco Dynamics/ Response, Susceptibility) Market Sales by Geography (USD MN)
  • Analysis by Therapeutic Area (USD MN)
  • Cardiovascular And Metabolic Disorders (CVMD) Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Psychiatric Disorders Market Sales by Geography (USD MN)
  • Sleep & Movement Disease Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Musculoskeletal Disorders Market Sales by Geography (USD MN)
  • Others (Diabetes, Pain Management) Market Sales by Geography (USD MN)
  • Analysis by End-Use (USD MN)
  • Healthcare Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Payers Market Sales by Geography (USD MN)
  • Others (Patient, Caregivers) Market Sales by Geography (USD MN)
  • Global Digital Biomarkers Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Digital Biomarkers Report
  • Market Research Process
  • Market Research Methodology
  • Global Digital Biomarkers Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Clinical Practice
  • Market Attractiveness Analysis by Therapeutic Area
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Wearable Market Sales by Geography (USD MN)
  • Mobile Based Applications Market Sales by Geography (USD MN)
  • Sensors Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Clinical Practice (USD MN)
  • Diagnostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Monitoring Digital Biomarkers Market Sales by Geography (USD MN)
  • Predictive And Prognostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Other's (Safety, Pharmaco Dynamics/ Response, Susceptibility) Market Sales by Geography (USD MN)
  • Global Market Analysis by Therapeutic Area (USD MN)
  • Cardiovascular And Metabolic Disorders (CVMD) Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Psychiatric Disorders Market Sales by Geography (USD MN)
  • Sleep & Movement Disease Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Musculoskeletal Disorders Market Sales by Geography (USD MN)
  • Others (Diabetes, Pain Management) Market Sales by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Healthcare Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Payers Market Sales by Geography (USD MN)
  • Others (Patient, Caregivers) Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112111961

The global demand for Digital Biomarkers Market is presumed to reach the market size of nearly USD 19.48 BN by 2030 from USD 3.6 BN in 2022 with a CAGR of 23.5% under the study period 2023 - 2030.

Digital biomarkers refer to measurable and quantifiable health-related data collected through digital devices and technologies, including wearables, smartphones, sensors, and other connected tools. These data points are used to monitor and analyze various aspects of an individual's health and behaviour in real time. These biomarkers provide valuable insights into a person's physiological, psychological, and behavioural patterns, enabling healthcare professionals and researchers to obtain a more holistic understanding of their well-being.

MARKET DYNAMICS:

The Digital biomarkers market is experiencing robust growth due to a combination of factors propelling the integration of technology into healthcare. Advancements in wearable devices, remote monitoring, and data analytics enable the collection of real-time health data, forming the basis for digital biomarkers. These biomarkers facilitate personalized healthcare, preventive approaches, and early detection of health issues. The wide adoption of smartphones, coupled with an ageing population and rising chronic diseases, fuels the demand for remote monitoring solutions. These biomarkers also find utility in mental health monitoring and clinical trials, while regulatory support and consumer awareness further drive their adoption. Nonetheless, challenges like data privacy and accuracy necessitate attention. The convergence of technology, healthcare needs, and patient empowerment underpins the expanding Digital biomarkers market, revolutionizing healthcare delivery and research methodologies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of digital biomarkers. The growth and trends of digital biomarkers industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the digital biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Wearable
  • Mobile Based Applications
  • Sensors
  • Others

By Clinical Practice

  • Diagnostic Digital Biomarkers
  • Monitoring Digital Biomarkers
  • Predictive And Prognostic Digital Biomarkers
  • Other'S (Safety, Pharmaco Dynamics/ Response, Susceptibility)

By Therapeutic Area

  • Cardiovascular And Metabolic Disorders (CVMD)
  • Respiratory Disorders
  • Psychiatric Disorders
  • Sleep & Movement Disease
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Others (Diabetes, Pain Management)

By End-Use

  • Healthcare Companies
  • Healthcare Providers
  • Payers
  • Others (Patient, Caregivers)

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Digital Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Digital Biomarkers market include ActiGraph LLC, AliveCor Inc., Koneksa, Altoida Inc., Amgen Inc., Biogen Inc., Empatica Inc., Vivo Sense, IXICO plc, Adherium Limited, Neurotrack Technologies, Inc., Aural Analytic, Huma, Sonde Health, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . DIGITAL BIOMARKERS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Clinical Practice
    • 3.7.3 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.4 Market Attractiveness Analysis By End-Use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Wearable Historic and Forecast Sales by Regions
  • 5.5 Mobile Based Applications Historic and Forecast Sales by Regions
  • 5.6 Sensors Historic and Forecast Sales by Regions
  • 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY CLINICAL PRACTICE

  • 6.1 Overview by Clinical Practice
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Clinical Practice
  • 6.4 Diagnostic Digital Biomarkers Historic and Forecast Sales by Regions
  • 6.5 Monitoring Digital Biomarkers Historic and Forecast Sales by Regions
  • 6.6 Predictive And Prognostic Digital Biomarkers Historic and Forecast Sales by Regions
  • 6.7 Other's (Safety, Pharmaco Dynamics/ Response, Susceptibility) Historic and Forecast Sales by Regions

7 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY THERAPEUTIC AREA

  • 7.1 Overview by Therapeutic Area
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Therapeutic Area
  • 7.4 Cardiovascular And Metabolic Disorders (CVMD) Historic and Forecast Sales by Regions
  • 7.5 Respiratory Disorders Historic and Forecast Sales by Regions
  • 7.6 Psychiatric Disorders Historic and Forecast Sales by Regions
  • 7.7 Sleep & Movement Disease Historic and Forecast Sales by Regions
  • 7.8 Neurological Disorders Historic and Forecast Sales by Regions
  • 7.9 Musculoskeletal Disorders Historic and Forecast Sales by Regions
  • 7.10. Others (Diabetes, Pain Management) Historic and Forecast Sales by Regions

8 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY END-USE

  • 8.1 Overview by End-Use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-Use
  • 8.4 Healthcare Companies Historic and Forecast Sales by Regions
  • 8.5 Healthcare Providers Historic and Forecast Sales by Regions
  • 8.6 Payers Historic and Forecast Sales by Regions
  • 8.7 Others (Patient, Caregivers) Historic and Forecast Sales by Regions

9 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE DIGITAL BIOMARKERS COMPANIES

  • 10.1. Digital Biomarkers Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF DIGITAL BIOMARKERS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. ActiGraph LLC
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. AliveCor Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Koneksa
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Altoida Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Amgen Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Biogen Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Empatica Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Vivo Sense
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. IXICO plc
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Adherium Limited
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Neurotrack Technologies Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Aural Analytic
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Huma
    • 11.15.1. Company Overview
    • 11.15.2. Company Revenue
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. Sonde Health Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Company Revenue
    • 11.16.3. Products
    • 11.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies